1. McMurray JJ, Pfeffer MA. Heart failure. Lancet. 2005;365:1877–89.
2. Saini-Chohan H, Hatch GM. Biological actions and metabolism of currently used pharmaceutical agents for the treatment of congestive heart failure. Curr Drug Metabol. 2009;10:206–19.
3. White DA. The phospholipid composition of mammalian tissues. In: Ansell GB, Hawthorne JN, Dawson RMC, editors. Form and function of phospholipids. Amsterdam: Elsevier; 1982. p. 441–82.
4. Reig J, Domingo E, Segura R, et al. Rat myocardial tissue lipids and their effect on ventricular electrical activity: influence on dietary lipids. Cardiovasc Res. 1993;27:364–70.
5. Hostetler KY. Polyglycerophospholipids: phosphatidylglycerol, di phosphatidylglyceroland bis(monoacylglycero)phosphate. In: Hawthorne JN, Ansell GB, editors. Phospholipids. Amsterdam: Elsevier; 1982. p. 215–61.